Key Points The sale involved shares equal to 10% of the CFO's direct equity stake held prior to the transaction. Activity was limited to direct ownership; no indirect holdings through trusts or other entities were disclosed in the filing. The disposal was executed under a Rule 10b5-1 trading plan established on June 1, 2026, facilitating pre-scheduled portfolio management. 10 stocks we like better than ICU Medical › Brian Michael Bonnell, Chief Financial Officer of ICU Medical (NASDAQ:ICUI) , sold 6,381 shares of common stock on Sept. 1, 2026, according to a recent SEC Form 4 filing . Transaction summary Transaction value based on SEC Form 4 weighted average sale price ($175); post-transaction value based on Sept. 1, 2026, market close ($170.81).
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.